Pacira BioSciences (PCRX) Leases: 2019-2025
Historic Leases for Pacira BioSciences (PCRX) over the last 7 years, with Sep 2025 value amounting to $44.3 million.
- Pacira BioSciences' Leases fell 17.77% to $44.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.3 million, marking a year-over-year decrease of 17.77%. This contributed to the annual value of $49.2 million for FY2024, which is 19.33% down from last year.
- Pacira BioSciences' Leases amounted to $44.3 million in Q3 2025, which was down 4.86% from $46.5 million recorded in Q2 2025.
- In the past 5 years, Pacira BioSciences' Leases registered a high of $76.4 million during Q4 2021, and its lowest value of $44.3 million during Q3 2025.
- Its 3-year average for Leases is $56.0 million, with a median of $56.3 million in 2024.
- As far as peak fluctuations go, Pacira BioSciences' Leases skyrocketed by 93.78% in 2021, and later dropped by 19.33% in 2024.
- Pacira BioSciences' Leases (MRQ) stood at $76.4 million in 2021, then decreased by 7.24% to $70.9 million in 2022, then fell by 13.91% to $61.0 million in 2023, then dropped by 19.33% to $49.2 million in 2024, then decreased by 10.07% to $44.3 million in 2025.
- Its last three reported values are $44.3 million in Q3 2025, $46.5 million for Q2 2025, and $48.7 million during Q1 2025.